Skip to content
Project Directory
  • Français
Donate Now
  • Français
  • About
    • What We Do
    • Leadership
    • Team
    • Publications
    • Careers
  • Diseases/Disorders
    • One Brain
    • ALS
    • Alzheimer’s
    • Autism
    • Brain Cancer
    • Brain Injury
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • Other
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
  • Ways To Give
    • Giving to Research
    • How You Can Help
    • Events

Funded Grants

Back to results

The endocannabinoid system: a master regulator of brain and gut health in mood disorders

Project Overview

Depression will affect 1 out of 5 individuals in their lifetime. Antidepressant treatments are not effective for 30-50% patients, only 30% completely remit and do not suffer from another depressive episode, suggesting that current therapies do not address important biological mechanisms involved such as neurovascular dysfunction or inflammation, which are receiving increasing attention in psychiatry. Depression is more prevalent and recurrent in patients affected by cardiovascular diseases and stroke and, conversely, depressed individuals are more at risk to develop these pathologies, suggesting a relationship between vascular dysfunction and this mood disorder.

We showed that chronic social stress induces blood-brain barrier (BBB) leakage in male mice, promoting depressive behaviors. The BBB is the ultimate frontier between the brain and harmful toxins or inflammatory signals circulating in the blood. The endocannabinoid system can regulate BBB permeability and has been associated with stress responses. It is composed of endocannabinoids, which are endogenous lipid-based neurotransmitters that bind to cannabinoid receptors, and cannabinoid receptor proteins that are expressed throughout the central nervous system and peripheral organs. The endocannabinoid system is involved in the pharmacological effects of cannabis but also several biological processes including pain, immune response and changes in the intestinal microbiota. The gut microbiota is disrupted in depressed patients leading to increased inflammation and gut barrier hyperpermeability. Thus, loss of the BBB permeability induced by chronic stress could come from changes in the microbiome endocannabinoid environment leading to release of inflammatory signals in the circulation, subsequent vascular dysfunction and establishment of depressive behaviors.

We propose here to evaluate if the endocannabinoid system could represent a promising target to promote neurovascular health and stress resilience by using a multidisciplinary and translational approach combining experiments performed in mice to validation in human samples including from women and Northern populations.

Principal Investigator

Caroline Menard , Université Laval

Partners and Donors

The Azrieli Foundation

Project Ongoing

The endocannabinoid system: a master regulator of brain and gut health in mood disorders

  • Program Type

    Capacity building grants

  • Area of research

    Mental Health

  • Disease Area

    Mental illness

  • Competition

    Future Leaders in Canadian Brain Research

  • Province

    Québec

  • Start Date

    2020

  • Total Grant Amount

    $100,000

Contact Us

1200 McGill College Avenue
Suite 1600, Montreal, Quebec
H3B 4G7

+1 (514) 989-2989 info@braincanada.ca

Playing with Marbles Podcast

Join us and take a journey to the real last great frontier – the brain.

Listen

Subscribe to Brain News

Receive our monthly electronic newsletter with updates on funded projects, upcoming events and breakthroughs in brain research.

Sign Up

Territorial acknowledgement

The offices of Brain Canada Foundation are located on the traditional, ancestral territory of the Kanien'kehá:ka Peoples, a place which has long served as a site of meeting and exchange amongst nations. We honour and pay respect to elders past, present and emerging, and dedicate ourselves to moving forward in the spirit of partnership, collaboration, and reconciliation. In our work, we focus our efforts on the Truth and Reconciliation Commission’s Calls to Action, particularly those that pertain to improving health for Indigenous Peoples and that focus on advancing our own learning on Indigenous issues.

© 2023 Brain Canada Foundation

Registration number: 89105 2094 RR0001

  • Terms and Conditions
  • Privacy Policy

Design by Field Trip & Co